Compare · ELV vs VRDN
ELV vs VRDN
Side-by-side comparison of Elevance Health Inc. (ELV) and Viridian Therapeutics Inc. (VRDN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ELV and VRDN operate in Medical Specialities (Health Care), so they compete in similar markets.
- ELV is the larger of the two at $80.98B, about 46.2x VRDN ($1.75B).
- VRDN has been more active in the news (15 items in the past 4 weeks vs 7 for ELV).
- VRDN has more recent analyst coverage (25 ratings vs 22 for ELV).
- Company
- Elevance Health Inc.
- Viridian Therapeutics Inc.
- Price
- $375.20+0.63%
- $16.59-2.38%
- Market cap
- $80.98B
- $1.75B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NYSE
- NASDAQ
- IPO
- 2014
- News (4w)
- 7
- 15
- Recent ratings
- 22
- 25
Elevance Health Inc.
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
Viridian Therapeutics Inc.
Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody for the treatment of thyroid eye disease; VRDN-002, a biosuperior IGF-1R antibody; and VRDN-003, an IGF-1R antibody product specifically designed for thyroid eye disease. The company was formerly known as Miragen Therapeutics, Inc. and changed its name to Viridian Therapeutics, Inc. in January 2021. Viridian Therapeutics, Inc. was founded in 2006 and is based in Boulder, Colorado.
Latest ELV
- Elevance Health Advances Efforts to Close Critical Gaps in Mental Health Care
- Elevance Health Names Best in Class Primary Care Practices in Care Provider Recognition Program
- Elevance Health's Affiliated Health Plans Deliver More Predictable, Lower Healthcare Costs for Small Businesses
- Elevance Health upgraded by BofA Securities with a new price target
- SEC Form 10-Q filed by Elevance Health Inc.
- Elevance Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Elevance Health Reports First Quarter 2026 Results; Raises Full-Year Guidance
- Evercore ISI initiated coverage on Elevance Health with a new price target
- SEC Form PX14A6G filed by Elevance Health Inc.
- Elevance Health Announces Leadership Appointments to Strengthen Execution and Drive Growth
Latest VRDN
- SEC Form FWP filed by Viridian Therapeutics Inc.
- SEC Form FWP filed by Viridian Therapeutics Inc.
- SEC Form 305B2 filed by Viridian Therapeutics Inc.
- Viridian Therapeutics Announces Pricing of Upsized Concurrent Public Offerings of 1.75% Convertible Senior Notes Due 2032 and Common Stock with Aggregate Gross Proceeds of $350.0 Million
- SEC Form 424B5 filed by Viridian Therapeutics Inc.
- SEC Form 424B5 filed by Viridian Therapeutics Inc.
- SEC Form FWP filed by Viridian Therapeutics Inc.
- Viridian Therapeutics Announces Proposed Concurrent Public Offerings of Convertible Senior Notes Due 2032, Common Stock and Series B Non-Voting Convertible Preferred Stock
- Viridian Therapeutics Inc. filed SEC Form 8-K: Regulation FD Disclosure
- SEC Form 10-Q filed by Viridian Therapeutics Inc.